AtriCure ATRC Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue from Contract with Customer, Excluding Assessed Tax by Product | ||||||
| Appendage management | $60.01M+5.5% | $56.89M+2.3% | $55.62M-0.5% | $55.91M+8.0% | $51.77M+4.3% | |
| Minimally invasive ablation | $8.3M-15.8% | $9.85M+6.0% | $9.29M-9.0% | $10.21M-2.7% | $10.49M-19.4% | |
| Open ablation | $48.6M-1.5% | $49.32M+6.2% | $46.44M-0.8% | $46.82M+10.7% | $42.3M+0.7% | |
| Pain management | $24.35M-0.4% | $24.44M+6.6% | $22.92M-1.2% | $23.2M+21.7% | $19.06M-3.0% | |
| Revenue from Contract with Customer, Excluding Assessed Tax by Geography | ||||||
| Asia Pacific | $7.08M— | —— | —— | —— | $6.78M-0.9% | |
| Europe | $16.07M+0.5% | $15.99M+5.4% | $15.17M-6.0% | $16.13M+13.6% | $14.2M+3.8% | |
| Other International | $1.89M+5.0% | $1.8M+5.5% | $1.71M-11.9% | $1.94M+30.2% | $1.49M-4.4% | |
| Total International | $25.04M-4.3% | $26.17M+4.8% | $24.96M-2.3% | $25.56M+13.7% | $22.47M-1.0% | |
| United States | $116.21M+1.6% | $114.33M+4.6% | $109.31M-1.2% | $110.58M+9.3% | $101.15M-0.4% | |
| Long-Lived Assets by Geography | ||||||
| Europe | $6.02M-4.4% | $6.29M+6.8% | $5.89M-2.4% | $6.03M+6.4% | $5.67M+41.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does AtriCure break its business down?
- AtriCure (ATRC) reports revenue from contract with customer, excluding assessed tax by product across 4 parts — Appendage management, Minimally invasive ablation, Open ablation and Pain management. Each is extracted from the segment footnotes and tracked over time.
- Where does AtriCure's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in AtriCure's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
